4//SEC Filing
Tari Leslie 4
Accession 0001610618-23-000030
CIK 0001610618other
Filed
Mar 28, 8:00 PM ET
Accepted
Mar 29, 5:26 PM ET
Size
11.4 KB
Accession
0001610618-23-000030
Insider Transaction Report
Form 4
Tari Leslie
CHIEF SCIENTIFIC OFFICER
Transactions
- Award
Common Stock
2023-03-27+90,000→ 280,179 total - Award
Employee Stock Option (right to buy)
2023-03-27+180,000→ 180,000 totalExercise: $1.01Exp: 2033-03-26→ Common Stock (180,000 underlying)
Holdings
- 1,484(indirect: By Spouse)
Common Stock
Footnotes (2)
- [F1]Represents time-based Restricted Stock Units (RSUs) granted on March 27, 2023. All RSUs vest in three equal annual installments, with 1/3 vesting on each of March 10, 2024, 2025, and 2026, subject to continuous service through each such vesting date.
- [F2]The option shall vest and become exercisable in a series of thirty-six (36) successive equal monthly installments measured from the Vesting Commencement Date of March 27, 2023.
Issuer
Cidara Therapeutics, Inc.
CIK 0001610618
Entity typeother
Related Parties
1- filerCIK 0001870270
Filing Metadata
- Form type
- 4
- Filed
- Mar 28, 8:00 PM ET
- Accepted
- Mar 29, 5:26 PM ET
- Size
- 11.4 KB